Meissa Vaccines
Meissa Vaccines is a private biotech company focused on the advancement of vaccines for respiratory syncytial virus (RSV), the largest unmet respiratory medical need in pediatrics, and rhinovirus, the leading cause of infectious disease worldwide. The company is also developing vaccines for parainfluenza and human metapneumovirus. Meissa Vaccines was founded on proprietary technologies employing synthetic biologic and reverse genetics to create safer, more effective vaccines.